Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815054) titled 'Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With Surgical' on Sept. 7.

Study Type: Observational

Primary Sponsor: The First Hospital of Jilin University

Condition: Hepatocellular Carcinoma (HCC)

Intervention: Procedure: Microwave Ablation Assisted by Diaphragm Hydrodissection

Recruitment Status: Not recruiting

Date of First Enrollment: October 1, 2026

Target Sample Size: 200

To know more, visit https://clinicaltrials.gov/study/NCT07815054

Published by HT Digital Content Services with permission from Health Daily Dig...